Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders

Details for Australian Patent Application No. 2003220743 (hide)

Owner Sepracor, Inc.

Inventors Rubin, Paul D; Barberich, Timothy J

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003220743

Parent 44333

Filing date 23 July 2003

Wipo publication date 14 August 2003

Acceptance publication date 15 June 2006

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

7 August 2003 Complete Application Filed

14 August 2003 Application Open to Public Inspection

  Published as AU-B-2003220743

15 June 2006 Application Accepted

  Published as AU-B-2003220743

12 October 2006 Standard Patent Sealed

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220744-Noise Barrier

2003220742-A storage wagon including a sensor device